NYSE:JRS Nuveen Real Estate Income Fund - JRS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nuveen Real Estate Income Fund Please log in to your account or sign up in order to add this asset to your watchlist. $7.06 +0.06 (+0.86%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$6.98▼$7.0850-Day Range$7.00▼$9.0352-Week Range$6.98▼$12.11Volume61,483 shsAverage Volume84,477 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield11.19%Price TargetN/A ProfileChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Nuveen Real Estate Income Fund (NYSE:JRS) StockNuveen Real Estate Income Fund is a closed-ended equity mutual fund launched by Nuveen Investments Inc. The fund is managed by Security Capital Research & Management Incorporated. It invests in the public equity markets of the United States. The fund makes its investments in stocks of companies operating in the real-estate sector. It typically invests in growth stocks of companies operating across all market capitalizations. Nuveen Real Estate Income Fund was formed on November 15, 2001 and is domiciled in the United States.Read More Receive JRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuveen Real Estate Income Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address JRS Stock News HeadlinesMarch 5, 2023 | marketbeat.comThese 9%+ Dividends Could Set You “Financially Free” TomorrowMarch 16, 2023 | seekingalpha.comNuveen Real Estate Income Fund goes ex dividend tomorrowMarch 25, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.February 21, 2023 | msn.comTop 3 Nuveen Mutual Funds for a Stellar PortfolioFebruary 21, 2023 | forbes.comFinancial Freedom Is 1 Click Away (Thanks To These 9%+ Dividends)January 10, 2023 | investing.comNuveen Real Estate Securities Fund Class R6 (FREGX)December 15, 2022 | bloomberg.comNuveen Trader Charged in $47 Million Insider SchemeSeptember 15, 2022 | seekingalpha.comNuveen Real Estate Income Fund goes ex-dividend tomorrowMarch 25, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.September 10, 2022 | msn.comReal estate transactions: Nuveen buys 6-building logistics portfolio in SpringAugust 25, 2022 | msn.comAttention retirees: Here are two CEFs yielding as high as 8.6% for stable income and inflation protectionAugust 17, 2022 | msn.comNorway’s wealth fund loses record $174bn in first half of 2022August 16, 2022 | seekingalpha.comJRS: Real Estate Having A Challenging 2022July 8, 2022 | marketwatch.comRealty Income Corp. stock outperforms market on strong trading dayApril 15, 2022 | seekingalpha.comA Quick Look At Our Real Estate Re-Investment Options: IGR Is Our Current FavoriteJanuary 13, 2022 | nasdaq.comNuveen Real Estate Income Fund Common Shares of Beneficial Interest (JRS)December 20, 2021 | nasdaq.comTake On Wall Street With These Nimble Funds Paying Up to 10%April 28, 2021 | nasdaq.comNuveen Core Plus Impact Fund (NPCT)April 28, 2021 | msn.com3 TIAA Mutual Funds That Deserve Your AttentionApril 13, 2021 | markets.businessinsider.comSchechter Investment Advisors Adds Joseph Drozd as a Senior Investment AdvisorMarch 27, 2021 | seekingalpha.comJRS: Real Estate Funds Heading Higher, With This Fund Still Showing ValueFebruary 22, 2021 | msn.comWhat Trump tax returns may reveal following Supreme Court rulingDecember 21, 2020 | msn.comRoger W. Ferguson, Jr.: Making Capitalism More InclusiveNovember 22, 2020 | msn.comMassachusetts real estate transactions for Hampden, Hampshire and Franklin counties Nov. 22, 2020October 16, 2020 | barrons.comPreferred Stocks’ Yields Are Dropping. These 5 Are Still Worth Buying.September 11, 2020 | seekingalpha.comNuveen Real Estate Income Fund goes ex-dividend on MondayAugust 20, 2020 | bloomberg.comTrillion-Dollar Fund Manager Taps Alternatives in Hunt for YieldSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive JRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuveen Real Estate Income Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address JRS Company Calendar Ex-Dividend for 12/30 Dividend12/14/2022Dividend Payable12/30/2022Ex-Dividend for 4/3 Dividend3/14/2023Today3/25/2023Dividend Payable4/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Asset Management Sub-IndustryN/A SectorFinance Current SymbolNYSE:JRS CUSIPN/A CIK1158289 Webwww.nuveen.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$-122,864,541.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Anthony R. Manno Jr. (Age 69)CPA, Portfolio Mang. Key Competitorsabrdn Global Premier Properties FundNYSE:AWPAdvent Convertible and Income FundNYSE:AVKApollo Senior Floating Rate FundNYSE:AFTBarings Global Short Duration High Yield FundNYSE:BGHBlackRock Core Bond TrustNYSE:BHKView All CompetitorsInsiders & InstitutionsNorthwestern Mutual Wealth Management Co.Sold 4,488 shares on 2/21/2023Ownership: 0.000%Morgan StanleySold 164,502 shares on 2/15/2023Ownership: 0.000%Ancora Advisors LLCSold 3,146 shares on 2/15/2023Ownership: 0.000%Cetera Advisor Networks LLCBought 17,508 shares on 2/14/2023Ownership: 0.000%Cetera Investment AdvisersBought 15,557 shares on 2/14/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions JRS Stock - Frequently Asked Questions How have JRS shares performed in 2023? Nuveen Real Estate Income Fund's stock was trading at $7.56 at the start of the year. Since then, JRS stock has decreased by 6.6% and is now trading at $7.06. View the best growth stocks for 2023 here. Are investors shorting Nuveen Real Estate Income Fund? Nuveen Real Estate Income Fund saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 144,000 shares, an increase of 778.0% from the February 13th total of 16,400 shares. Based on an average daily volume of 88,600 shares, the days-to-cover ratio is presently 1.6 days. View Nuveen Real Estate Income Fund's Short Interest. How often does Nuveen Real Estate Income Fund pay dividends? What is the dividend yield for Nuveen Real Estate Income Fund? Nuveen Real Estate Income Fund announced a quarterly dividend on Wednesday, March 1st. Shareholders of record on Wednesday, March 15th will be given a dividend of $0.17 per share on Monday, April 3rd. This represents a $0.68 annualized dividend and a yield of 9.63%. The ex-dividend date of this dividend is Tuesday, March 14th. Read our dividend analysis for JRS. Is Nuveen Real Estate Income Fund a good dividend stock? Nuveen Real Estate Income Fund (NYSE:JRS) pays an annual dividend of $0.79 per share and currently has a dividend yield of 0.09%. Read our dividend analysis for JRS. What other stocks do shareholders of Nuveen Real Estate Income Fund own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen Real Estate Income Fund investors own include Main Street Capital (MAIN), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Chevron (CVX), International Business Machines (IBM), Walt Disney (DIS), EPR Properties (EPR), Energy Transfer (ET) and Alphabet (GOOG). What is Nuveen Real Estate Income Fund's stock symbol? Nuveen Real Estate Income Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "JRS." Who are Nuveen Real Estate Income Fund's major shareholders? Nuveen Real Estate Income Fund's stock is owned by many different institutional and retail investors. Top institutional investors include Morgan Stanley (0.00%), Advisors Asset Management Inc. (0.00%), Commonwealth Equity Services LLC (0.00%), Baird Financial Group Inc. (0.00%), Private Advisor Group LLC (0.00%) and LPL Financial LLC (0.00%). View institutional ownership trends. How do I buy shares of Nuveen Real Estate Income Fund? Shares of JRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Nuveen Real Estate Income Fund's stock price today? One share of JRS stock can currently be purchased for approximately $7.06. This page (NYSE:JRS) was last updated on 3/25/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.